Your browser doesn't support javascript.
loading
Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb.
Wollenberg, Andreas; Howell, Michael D; Guttman-Yassky, Emma; Silverberg, Jonathan I; Kell, Christopher; Ranade, Koustubh; Moate, Rachel; van der Merwe, René.
  • Wollenberg A; Department of Dermatology and Allergy, Ludwig Maximillian University, Munich, Germany. Electronic address: wollenberg@lrz.uni-muenchen.de.
  • Howell MD; Translational Medicine, MedImmune, Gaithersburg, Md.
  • Guttman-Yassky E; Department of Dermatology, Icahn School of Medicine at the Mount Sinai Medical Center Medicine, New York, NY.
  • Silverberg JI; Department of Dermatology, Preventive Medicine and Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Ill.
  • Kell C; Product Development, MedImmune, Cambridge, United Kingdom.
  • Ranade K; Translational Medicine, MedImmune, Gaithersburg, Md.
  • Moate R; Clinical Statistics and Data, MedImmune, Cambridge, United Kingdom.
  • van der Merwe R; Clinical Respiratory Management, MedImmune, Cambridge, United Kingdom.
J Allergy Clin Immunol ; 143(1): 135-141, 2019 01.
Article en En | MEDLINE | ID: mdl-29906525
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Interleucina-13 / Dermatitis Atópica / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Interleucina-13 / Dermatitis Atópica / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article